




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Vascular Medicine</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=0b213bea-9a50-4a88-aa7f-678a7be1de93</link>
        <description>Clinical Topic Feed: Vascular Medicine</description>
        <language>en</language>

        

                <item>
                    <title>Rising HDP Rates in the US; BP Monitoring Across the Lifespan</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/Rising-HDP-Rates-in-the-US</link>                    <description>The rate of new-onset hypertensive disorders of pregnancy (HDP) in the U.S. increased significantly from 2016 to 2024 across all racial and ethnic groups, according to a brief JACC report &#226;€“ the importance of which is further echoed in a longer systematic review of blood pressure (BP) monitoring across a patient&#39;s lifespan published in JACC&#39;s May 12 hypertension focus issue.</description>
                    <pubdate>1778688120000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>AI-Enabled Clinician: Patient Engagement and Care Transformation with AI-Quantified Plaque Analysis</title>
<link>/Latest-in-Cardiology/Articles/2026/05/07/15/36/ai-enabled-clinician-07may2026</link>                    <description>In this episode, Chief Innovation Officer, Ami Bhatt, MD, FACC and Allen Taylor, MD, FACC discuss the importance of cardiovascular prevention and early screening through AI-quantified plaque analysis by drawing parallels to how oncology and gastroenterology approach early detection.</description>
                    <pubdate>1778168340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | Evolocumab Cuts Risk in Absence of ASCVD: Sotatercept For CpCPH, HFpEF</title>
<link>/Latest-in-Cardiology/Articles/2026/05/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1777637340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Featured Jobs For May 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1777629480000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Preventing Pregnancy-Related CVD and Maternal Mortality in the US</title>
<link>/Latest-in-Cardiology/Articles/2026/04/30/10/29/Preventing-Pregnancy-Related-CVD</link>                    <description>A new report from the National Academies of Sciences, Engineering, and Medicine calls for &quot;stronger clinical preventive services, better follow-up after delivery, and improved care coordination across the reproductive life course&quot; to better manage cardiovascular disease risk in pregnant and postpartum patients...</description>
                    <pubdate>1777573140000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Can Cardiorespiratory Fitness Lead to Longer Lifespans?</title>
<link>/Latest-in-Cardiology/Articles/2026/04/29/14/55/eagles-eye-view-29apr2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at endovascular therapy for post-thrombotic syndrome and how it reduces severity and improves quality of life.</description>
                    <pubdate>1777474620000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Heart Failure Trials Featured at ACC.26</title>
<link>/Latest-in-Cardiology/Articles/2026/04/27/19/07/Heart-Failure-Trials-Featured-at-ACC26</link>                    <description>ACC.26 featured several late-breaking heart failure clinical trials, including two focused on subgroups of heart failure that until now had limited data to guide therapies.</description>
                    <pubdate>1777460220000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Implications of ACC.26 Prevention Trials For Future Guidelines</title>
<link>/Latest-in-Cardiology/Articles/2026/04/27/19/07/Implications-of-ACC26-Prevention-Trials-For-Future-Guidelines</link>                    <description>The VESALIUS-CV trial primary prevention analysis was a prespecified evaluation of use of evolocumab in 3,655 trial participants who had elevated LDL cholesterol (LDL-C) values but no evidence of significant atherosclerotic cardiovascular disease (ASCVD), defined as no prior revascularization, no arterial stenosis...</description>
                    <pubdate>1777391340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>OCEANIC-STROKE: Asundexian Lowers Recurrent Stroke Risk in Patients With Noncardioembolic Stroke or TIA</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/04/22/11/23/OCEANIC-STROKE</link>                    <description>Asundexian lowered the risk of ischemic stroke and major cardiovascular events, without increasing the risk of major bleeding, in patients with noncardioembolic stroke or high-risk transient ischemic attack (TIA) taking antiplatelet therapy, according to results from the phase 3, double-blind OCEANIC-STROKE trial, published April 15 in NEJM.</description>
                    <pubdate>1776865440000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Current Evidence and Strategies to Address Sex Hormone-Associated Thrombotic and CV Risk</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/04/21/16/07/Current-Evidence-and-Strategies</link>                    <description>The influences of sex hormone therapy &#226;€“ for contraception, treatment of heavy menstrual bleeding, hormone-replacement therapy, gender-affirming care therapy, etc. &#226;€“ on venous thrombotic and cardiovascular risk was explored in a Review Article published April 15 in NEJM.</description>
                    <pubdate>1776793020000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>